background
indirect
evid
increas
infecti
burden
associ
decreas
preval
igemedi
allergi
childhood
object
determin
whether
relat
serostatu
differ
virus
parent
report
infect
ige
sensit
children
investig
whether
interact
cytomegaloviru
cmv
epsteinbarr
viru
ebv
relat
ige
sensit
method
total
infant
follow
prospect
year
age
clinic
examin
skin
prick
test
specif
ige
analys
analysi
seroposit
adenoviru
influenza
parainfluenza
respiratori
syncyti
viru
cmv
ebv
herp
simplex
viru
human
herpesviru
varicellazost
viru
result
evid
ige
sensit
tend
common
among
children
seroposit
compar
children
seroposit
mani
virus
statist
signific
consist
trend
across
group
ige
sensit
statist
significantli
less
preval
year
age
among
infant
seroposit
ebv
virus
adjust
odd
ratio
ci
interact
seroposit
cmv
ebv
antibodi
indic
reduct
risk
ige
sensit
adjust
odd
ratio
interact
ci
indic
effect
modif
associ
seroposit
cmv
conclus
result
indic
acquisit
ebv
infect
first
year
life
associ
reduc
risk
ige
sensit
effect
enhanc
cmv
coinfect
j
allergi
clin
immunol
increas
preval
allerg
diseas
becom
major
health
problem
industri
part
world
epidemiolog
studi
shown
variou
marker
increas
burden
infect
associ
decreas
preval
allergi
asthma
childhood
viral
infect
implic
influenc
igemedi
sensit
exact
role
remain
controversi
sugest
mani
virus
influenc
differenti
cell
thu
caus
imbal
h
h
immun
respons
cytomegaloviru
cmv
epsteinbarr
viru
ebv
persist
viral
infect
demonstr
frequent
presenc
viru
saliva
urin
healthi
individu
may
influenc
immun
system
respect
develop
allergi
recent
propos
sidorchuk
et
al
aim
studi
therefor
elucid
interplay
cmv
ebv
relat
ige
sensit
among
children
month
age
studi
also
design
investig
associ
ige
sensit
infecti
burden
measur
seropreval
differ
virus
includ
cmv
ebv
respiratori
syncyti
viru
rsv
well
parent
report
infect
famili
expect
child
ask
midwif
matern
ward
whether
interest
particip
studi
parent
report
histori
allergi
mother
parent
neither
parent
elig
parent
provid
blood
sampl
underw
skin
prick
test
spt
parent
whose
spt
result
confirm
posit
neg
histori
respiratori
allergi
pollen
andor
fur
pet
invit
continu
evalu
month
age
children
boy
girl
born
select
parent
particip
studi
one
hundr
two
children
allerg
parent
children
allerg
mother
children
parent
histori
allergi
infant
born
fullterm
week
gestat
hospit
stockholm
birth
weight
within
normal
rang
data
shown
socioeconom
statu
children
follow
birth
year
age
clinic
evalu
age
month
pediatrician
c
n
skin
prick
test
food
inhal
allergen
perform
among
children
month
age
accord
manufactur
recommend
alk
copenhagen
denmark
spt
includ
food
allergen
egg
white
soluprick
weight
volum
ratio
cod
soluprick
peanut
soluprick
cow
milk
fat
standard
milk
soybean
protein
soja
semp
semper
ab
stockholm
sweden
spt
also
perform
inhal
allergen
cat
dog
dermatophagoid
farina
birch
timothi
soluprick
histamin
equival
prick
test
parent
skin
prick
test
inhal
allergen
children
also
hors
rabbit
mugwort
histamin
chlorid
mgml
posit
control
allergen
diluent
neg
control
spt
consid
posit
wheal
diamet
mm
minut
observ
period
parent
ask
record
everi
infect
child
structur
diari
includ
symptomsrunni
nose
cough
vomit
diarrhea
feverand
doctor
diagnosi
relev
diari
consist
set
structur
question
set
ill
parent
fill
form
everi
time
child
ill
mark
correct
squar
x
record
date
ill
parent
confirm
event
record
diari
visit
outpati
clinic
child
age
month
attempt
record
miss
ill
visit
parent
ask
child
ill
sinc
last
visit
addit
ill
mention
ad
diari
venou
blood
sampl
collect
children
month
old
plasma
separ
centrifug
store
pend
analysi
circul
ige
antibodi
cow
milk
egg
white
peanut
cod
fish
soy
bean
wheat
cat
dander
dog
dander
birch
pollen
timothi
pollen
dermatophagoid
farina
determin
plasma
pharmacia
capfeia
pharmaciaupjohn
uppsala
sweden
posit
test
defin
ige
antibodi
level
kilo
unit
allergenspecif
antibodi
ku
per
liter
accord
johansson
et
al
child
classifi
igesensit
least
spt
posit
mm
andor
specif
ige
least
select
allergen
l
optim
classif
igesensit
nonigesensit
children
result
vivo
vitro
analysi
combin
serostatu
virus
investig
respiratori
tract
infect
includ
adenoviru
influenza
influenza
b
parainfluenza
type
rsv
herpesviru
includ
cmv
ebv
herp
simplex
viru
hsv
human
herpesviru
varicellazost
viru
vzv
igg
ebv
capsid
antigen
determin
accord
previous
publish
immunofluoresc
assay
specif
fluoresc
dilut
regard
sign
seroposit
hsv
cmv
vzv
igg
elisa
purifi
nuclear
antigen
respect
virus
cultiv
human
fetal
lung
fibroblast
use
cutoff
seroposit
absorb
dilut
igg
antibodi
influenza
influenza
b
determin
elisa
use
recombin
influenza
antigen
igg
antibodi
parainfluenza
serotyp
rsv
adenovirus
measur
elisa
virus
cultur
full
cytopathogen
effect
either
human
fetal
lung
fibroblast
rsv
adenoviru
cell
monkey
kidney
cell
parainfluenza
prepar
mainli
ultracentrifug
sonif
clarifi
supernat
adenoviru
sonic
infect
cell
use
prepar
respect
cell
line
use
control
antigen
assay
use
cell
cultur
antigen
optic
densiti
subtract
control
antigen
activ
regard
sign
past
infect
respiratori
virus
descript
statist
use
character
data
x
analysi
student
test
use
comparison
igesensit
nonigesensit
children
appropri
number
serolog
verifi
infect
normal
distribut
fig
parent
report
infect
close
normal
distribut
divid
quarter
defin
quartil
use
statist
program
spss
window
spss
inc
chicago
ill
variat
size
group
result
characterist
distribut
odd
ratio
ci
calcul
develop
ige
sensit
data
adjust
background
variabl
use
multipl
logist
regress
analysi
adjust
made
sex
parent
allergi
none
singlehered
doublehered
matern
age
parent
smoke
fur
pet
home
month
birth
older
sibl
durat
breastfeed
socioeconom
statu
parent
report
infect
seroposit
virus
measur
model
seri
binari
dummi
variabl
interact
seroposit
cmv
ebv
investig
use
logist
regress
adjust
main
effect
p
valu
consid
statist
signific
data
analyz
use
stata
stata
corp
colleg
station
tex
spss
window
sa
system
window
releas
sa
institut
cari
nc
children
averag
age
month
rang
evalu
fiftynin
children
classifi
igesensit
vitro
test
allergenspecif
ige
plasma
posit
infant
wherea
infant
least
posit
spt
select
food
inhal
allergen
major
n
sensit
food
allergen
sensit
toward
individu
allergen
milk
egg
peanut
dog
wheat
cat
birch
soy
fish
timothi
mite
statist
signific
differ
sex
fur
pet
home
smoke
parent
igesensit
nonsensit
children
tabl
howev
nonsensit
children
statist
significantli
like
born
summer
sensit
children
frequent
sibl
sensit
children
statist
significantli
like
atop
parent
statist
signific
associ
short
durat
breastfeed
observ
adjust
analys
suggest
complex
set
associ
chanc
find
median
number
parent
report
infect
rang
first
month
life
evalu
infant
divid
group
defin
quartil
report
infect
associ
ige
sensit
group
evalu
sensit
children
fewer
group
parent
report
infect
statist
signific
differ
group
trend
across
group
consist
tabl
ii
frequenc
seroposit
month
age
select
virus
present
tabl
ii
children
apart
detect
igg
antibodi
least
virus
studi
child
detect
igg
signific
associ
number
parent
report
infect
number
virus
identifi
serolog
data
shown
mean
number
virus
identifi
serolog
fig
children
divid
group
defin
quartil
fiftyf
children
antibodi
virus
children
virus
virus
virus
respect
suggest
children
fewer
antibodi
often
sensit
children
antibodi
mani
virus
result
statist
signific
tabl
ii
pattern
show
consist
trend
across
group
respiratori
virus
associ
presenc
antibodi
individu
virus
ige
sensit
present
tabl
ii
statist
signific
associ
ige
sensit
seroposit
airborn
virusesadenoviru
influenza
b
parainfluenza
type
rsv
sixtythre
percent
children
seroposit
rsv
month
age
among
n
igesensit
herpesvirus
seroposit
virus
belong
herpesviru
familycmv
ebv
hsv
vzvand
ige
sensit
also
present
tabl
ii
seroneg
ebv
statist
significantli
associ
ige
sensit
sixtyfour
children
seroposit
ebv
among
sensit
significantli
less
ebv
seroneg
group
odd
ratio
ci
associ
remain
statist
signific
adjust
potenti
confound
factor
tabl
ii
cytomegaloviru
igg
antibodi
detect
children
among
igesensit
statist
signific
differ
number
seroposit
seroneg
cmv
compar
ige
sensit
nonsensit
infant
howev
seroposit
ebv
neg
associ
sensit
among
subject
also
seroposit
cmv
odd
ratio
ige
sensit
associ
seroposit
ebv
among
children
seroneg
cmv
ci
reduc
ci
among
children
seroposit
virus
interact
test
reveal
statist
signific
synergist
effect
effect
modif
produc
odd
ratio
interact
virus
ige
sensit
ci
adjust
main
effect
also
observ
associ
sensit
among
subject
seroposit
cmv
seroneg
ebv
among
seroneg
ebv
n
sensit
among
infect
cmv
compar
infect
cmv
produc
odd
ratio
ci
suggest
modest
increas
risk
associ
cmv
infect
subject
seroneg
ebv
serostatu
herpesvirus
significantli
associ
ige
sensit
hypothesi
infecti
diseas
earli
childhood
may
protect
role
develop
allergi
hygien
hypothesi
rais
late
current
studi
find
strong
evid
associ
ige
sensit
number
previou
infect
indic
either
parent
report
seroposit
howev
ige
sensit
less
preval
year
age
among
infant
seroposit
ebv
combin
cmv
ebv
antibodi
strongli
neg
associ
sensit
would
predict
individu
associ
ebv
cmv
antibodi
alon
indic
interact
effect
preval
ebv
antibodi
studi
compar
industri
countri
previou
studi
ebv
contradictori
relat
develop
atopi
increas
level
antibodi
ebv
found
children
year
old
clinic
sign
atopi
compar
nonatop
counterpart
howev
calvani
et
al
report
higher
preval
atopi
among
ebv
seroneg
children
age
group
year
corrobor
result
recent
swedish
studi
bams
fail
demonstr
ebv
serostatu
children
correl
ige
sensit
develop
countri
ebv
asymptomat
infect
major
children
year
age
preval
atopi
report
lower
industri
countri
combin
find
observ
might
indic
agedepend
role
ebv
rather
ebv
infect
per
se
relat
ige
sensit
cytomegaloviru
becom
persist
primari
infect
seem
induc
h
cytokin
respons
cmv
frequent
transmit
mother
infant
pregnanc
deliveri
via
breast
milk
studi
publish
relat
cmv
allergi
inconclus
swedish
bams
studi
associ
found
cmv
seroposit
ige
sensit
children
howev
among
children
seroposit
cmv
seroneg
ebv
posit
associ
sensit
food
allergen
led
us
test
interact
seroposit
cmv
ebv
relat
ige
sensit
indic
effect
modif
neg
associ
ebv
seroposit
sensit
enhanc
children
also
seroposit
cmv
mechan
put
interact
unknown
sever
plausibl
explan
possibl
includ
idea
homologu
present
virus
might
downregul
antigen
processingpresent
capac
dendrit
cellsmacrophag
therebi
switch
host
tcell
system
similar
downregul
observ
regulatori
cell
altern
ebv
cmv
polyclon
activ
b
cell
produc
antibodi
mani
differ
specif
therebi
hinder
capac
allergen
crosslink
bcell
receptor
seen
helmint
infect
thu
data
result
provid
support
hypothesi
specif
characterist
ebv
andor
cmv
infect
rather
infect
per
se
might
influenc
risk
ige
sensit
interestingli
rsv
infect
accord
serolog
associ
ige
sensit
month
age
previou
studi
suggest
hospit
rsv
infect
link
atopi
induct
ige
synthesi
discrep
differ
studi
indic
vulner
rsv
might
associ
propens
asthma
allergi
rsv
per
se
caus
asthma
characterist
infect
may
import
identif
hospit
suggest
sever
acut
infect
major
children
studi
would
blancoquiro
et
al
report
infant
develop
sever
rsv
bronchiol
low
level
strong
h
induc
cord
blood
recent
publish
similar
data
show
low
level
cord
blood
ige
sensit
infant
month
age
observ
might
indic
interact
among
cytokin
rsv
sensit
earli
infanc
indic
number
serolog
verifi
viral
infect
invers
correl
ige
sensit
consist
trend
across
group
statist
signific
associ
number
parent
report
infect
seroposit
select
virus
correl
entir
surpris
mani
virus
eg
rhinoviru
corona
viru
propos
major
caus
upper
respiratori
infect
infant
includ
analysi
alway
relat
viral
infect
diseas
asymptomat
infect
common
suggest
invers
associ
frequenc
parent
report
serolog
verifi
viral
infect
sensit
agreement
previou
public
although
author
mainli
studi
clinic
sign
allergi
possibl
suggest
protect
effect
infect
continu
influenc
nascent
immun
system
beyond
age
year
followup
conduct
young
age
observ
protect
effect
allerg
diseas
previou
studi
shown
mainli
indirect
evid
import
infect
develop
allergi
studi
often
retrospect
strength
studi
atop
statu
parent
character
inform
infect
collect
prospect
use
diari
importantli
object
serolog
measur
antivir
antibodi
made
result
adjust
factor
might
bia
evalu
howev
recogn
limit
studi
popul
select
populationbas
select
children
differ
famili
histori
allergi
believ
group
children
studi
fairli
compar
children
gener
popul
furthermor
exact
sensit
seroposit
assay
use
evalu
respiratori
infect
fulli
known
use
mainli
detect
ongo
infect
rate
seroposit
somewhat
underestim
introduc
bia
optim
approach
would
perform
neutral
assay
serum
sampl
infant
inevit
insuffici
test
use
low
serum
dilut
contrast
sensit
specif
seroposit
assay
use
herpesviru
infect
proven
reliabl
best
demonstr
correl
initi
serostatu
clinic
outcom
found
transplant
recipi
could
also
argu
analyz
differ
virus
could
produc
associ
ige
sensit
chanc
howev
associ
specif
ebv
evalu
result
priori
hypothesi
base
result
previou
studi
associ
report
ebv
unlik
caus
chanc
summari
result
indic
ebv
infect
first
year
life
associ
reduc
risk
ige
sensit
pattern
infect
may
confer
greater
protect
ebv
infect
agedefin
window
suscept
possibl
modif
interact
cmv
develop
precis
measur
pattern
acut
infect
immunolog
sequel
assist
understand
earli
life
viral
infect
implic
etiolog
ige
sensit
